Antimicrobial Stewardship

Antimicrobial Stewardship

Developments in Emerging and Existing Infectious Diseases
2017, Pages 69-84
Antimicrobial Stewardship

Chapter 6 - Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship

https://doi.org/10.1016/B978-0-12-810477-4.00006-4Get rights and content

Abstract

Rapid diagnostic tests (RDTs) can speed the etiologic diagnosis of infections in several scenarios (e.g., sepsis, respiratory tract infections, and meningitis). Interpretation of currently available RDTs is not always straightforward, and therefore, they cannot yet replace conventional tests. Institutional priorities, integration with laboratory workflow, and cost are issues that have to be considered when selecting RDTs to implement locally. RDTs can improve antimicrobial prescribing at institutional level if the antimicrobial stewardship team is actively involved; however, this should always be monitored. Available biomarkers for infection detection, mainly C-reactive protein (CRP) and procalcitonin (PCT), are useful, when applied appropriately, to reduce antibiotic exposure in both the outpatient and inpatient setting, especially for acute respiratory tract infections. Biomarkers have to be used in combination with other available tools to diagnose infection, including the clinical scenario (outpatient, inpatient, and ICU), the pretest probability of infection, and patients' individual circumstances (i.e., immunocompromised or source of infection).

References (0)

Cited by (0)

View full text